These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 18239407)

  • 21. Mesalamine derivatives in the treatment of Crohn's disease.
    Harrell LE; Hanauer SB
    Gastroenterol Clin North Am; 2004 Jun; 33(2):303-17, ix-x. PubMed ID: 15177540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pregnancy in inflammatory bowel disease: effect of sulfasalazine and corticosteroids on fetal outcome.
    Mogadam M; Dobbins WO; Korelitz BI; Ahmed SW
    Gastroenterology; 1981 Jan; 80(1):72-6. PubMed ID: 6108894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Maintenance of surgically induced remission of Crohn's disease.
    Froehlich F; Juillerat P; Pittet V; Felley C; Mottet C; Vader JP; Michetti P; Gonvers JJ
    Digestion; 2007; 76(2):130-5. PubMed ID: 18239404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of chronic inflammatory bowel diseases].
    Lémann M
    Bull Acad Natl Med; 2007 Jun; 191(6):1125-41; discussion 1141. PubMed ID: 18402168
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [For treatment decision the age to be taken into account. In Crohn's disease and ulcerative colitis attention to be paid to the age at manifestation].
    MMW Fortschr Med; 2009 May; 151(19):38-9. PubMed ID: 19827443
    [No Abstract]   [Full Text] [Related]  

  • 26. Absence of infliximab in infants and breast milk from nursing mothers receiving therapy for Crohn's disease before and after delivery.
    Kane S; Ford J; Cohen R; Wagner C
    J Clin Gastroenterol; 2009 Aug; 43(7):613-6. PubMed ID: 19142167
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug insight: aminosalicylates for the treatment of IBD.
    Nielsen OH; Munck LK
    Nat Clin Pract Gastroenterol Hepatol; 2007 Mar; 4(3):160-70. PubMed ID: 17339853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug therapy for inflammatory bowel disease in pregnancy and the puerperium.
    Moffatt DC; Bernstein CN
    Best Pract Res Clin Gastroenterol; 2007; 21(5):835-47. PubMed ID: 17889811
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Crohn's disease as a risk factor for the outcome of pregnancy.
    Morales M; Berney T; Jenny A; Morel P; Extermann P
    Hepatogastroenterology; 2000; 47(36):1595-8. PubMed ID: 11149010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Crohn's disease and acute leukocytoclastic vasculitis of skin.
    Zlatanic J; Fleisher M; Sasson M; Kim P; Korelitz BI
    Am J Gastroenterol; 1996 Nov; 91(11):2410-3. PubMed ID: 8931427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Appropriate management of special situations in Crohn's disease (upper gastro-intestinal; extra-intestinal manifestations; drug safety during pregnancy and breastfeeding): Results of a multidisciplinary international expert panel-EPACT II.
    Mottet C; Vader JP; Felley C; Froehlich F; Gonvers JJ; Juillerat P; Stockbrügger R; Angelucci E; Seibold F; Michetti P; Pittet V;
    J Crohns Colitis; 2009 Dec; 3(4):257-63. PubMed ID: 21172284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methotrexate as single therapy in Crohn's disease: is its long-term efficacy limited?
    Charpignon C; Beau P
    Gastroenterol Clin Biol; 2008 Feb; 32(2):153-7. PubMed ID: 18343615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Diffuse alopecia as side effect of mesalazine therapy in Crohn's disease].
    Netzer P
    Schweiz Med Wochenschr; 1995 Dec; 125(50):2438-42. PubMed ID: 8553032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Review article: can post-operative recurrence in Crohn's disease be prevented?
    Lémann M
    Aliment Pharmacol Ther; 2006 Oct; 24 Suppl 3():22-8. PubMed ID: 16961740
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inflammatory bowel disease and pregnancy: report of two cases treated with infliximab and a review of the literature.
    Correia LM; Bonilha DQ; Ramos JD; Ambrogini O; Miszputen SJ
    Eur J Gastroenterol Hepatol; 2010 Oct; 22(10):1260-4. PubMed ID: 20671559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapy of mild to moderate luminal Crohn's disease.
    Michetti P; Juillerat P; Mottet C; Gonvers JJ; Burnand B; Vader JP; Froehlich F; Felley C
    Digestion; 2005; 71(1):13-8. PubMed ID: 15711043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mild-to-moderate active luminal Crohn's disease.
    Michetti P; Juillerat P; Mottet C; Pittet V; Gonvers JJ; Vader JP; Froehlich F; Felley C
    Digestion; 2007; 76(2):92-8. PubMed ID: 18239399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pancreatitis in a patient with Crohn disease treated with mesalazine and azathioprine].
    Glintborg B
    Ugeskr Laeger; 2000 Aug; 162(34):4553-4. PubMed ID: 10981226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Crohn's disease and pregnancy. A case report].
    Gudiño Molina FJ; Jinich Brook H; Montiel-Jarquin A; Rodríguez Torres LF
    Ginecol Obstet Mex; 1998 Feb; 66():62-4. PubMed ID: 9586389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mesalazine-induced lupus.
    Timsit MA; Anglicheau D; Lioté F; Marteau P; Dryll A
    Rev Rhum Engl Ed; 1997 Oct; 64(10):586-8. PubMed ID: 9385697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.